10-Q: Dogecoin Cash Reports Q2 2026 Results, Revenue Down 13%

Dogecoin Cash, Inc. reported a 13% decrease in revenue for the second quarter of 2026 compared to the prior year, driven by competitive pressures in the cannabis telemedicine industry, alongside a continued net loss.

Summary

• Dogecoin Cash, Inc. reported a 13% decrease in revenue for the three months ended June 30, 2026, totaling $166,511, compared to $192,464 in the same period of 2025.
• For the six months ended June 30, 2026, revenue decreased by 5% to $359,409 from $376,937 in the prior year.
• Total operating expenses decreased by 29% for the three-month period and 4% for the six-month period, largely due to reductions in general and administrative expenses.
• The company reported a net loss from continuing operations of $112,955 for the three months ended June 30, 2026, and $270,157 for the six months ended June 30, 2026.
• The company has an accumulated deficit of $84,714,880 as of June 30, 2026, raising substantial doubt about its ability to continue as a going concern.
• Cash on hand was $10,971 as of June 30, 2026, which is insufficient to meet immediate operational needs.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to significant revenue declines, persistent net losses, and a going concern warning, despite some expense reductions.

Positives

• Total operating expenses decreased by 29% for the three months ended June 30, 2026, to $217,515 from $304,892 in Q2 2025.
• General and administrative expenses saw a significant decrease of 42% in the three-month period.
• Wages and salaries decreased by 11% for the three-month period and 9% for the six-month period.
• Cost of revenues as a percentage of sales decreased by 1% for the six-month period, indicating improved efficiency.

Negatives

• Revenue for the three months ended June 30, 2026, decreased by 13% to $166,511 from $192,464 in the prior year.
• Revenue for the six months ended June 30, 2026, decreased by 5% to $359,409 from $376,937 in the prior year.
• The company reported a net loss of $137,706 for the three months ended June 30, 2026, and $338,176 for the six months ended June 30, 2026.
• The company has an accumulated deficit of $84,714,880 as of June 30, 2026.
• Cash on hand was only $10,971 as of June 30, 2026, insufficient for current operations.
• Material weaknesses were identified in disclosure controls and procedures due to the small size of the accounting staff.

Risks

• Sustained competitive pressure in the cannabis telemedicine industry is compressing demand growth.
• Intensifying market competition is a primary driver for the decrease in revenues.
• The company may need to raise capital through equity offerings, which will cause dilution to current shareholders.
• The small size of the accounting staff may prevent adequate internal controls in the future, such as segregation of duties, due to the cost/benefit of remediation.
• The company is evaluating whether to acquire a cyber liability insurance policy to mitigate financial impacts of a cybersecurity breach.

Future Outlook

The company may seek to raise money for working capital through public or private equity offerings or convertible debt. Success in raising capital is important for advancing the business plan aggressively, but will cause dilution to current shareholders. The current cash on hand is insufficient to meet immediate operational needs.

Management Comments

• Our CEO is responsible for overseeing our business operations and is responsible for day-to-day assessment and confers weekly with subsidiary webmaster to understand any risks from cybersecurity threats, including the prevention, mitigation, detection, and remediation of cybersecurity incidents.
• Management of the Company believes that these material weaknesses are due to the small size of the companys accounting staff.
• As the Company grows, management expects to increase the number of employees, which will enable us to implement adequate segregation of duties within the internal control framework.

Industry Context

StockSavvy.ai notes that the reported revenue decline and competitive pressures in the cannabis telemedicine industry align with broader market trends of increased competition and market saturation in specialized healthcare sectors.

Corporate Governance

Legal Proceedings

• No material legal proceedings are currently outstanding.
• The company is not a party to any material legal proceedings, and no such proceedings have been threatened.

Related Party Transactions

• Officers' wages for the three months ended June 30, 2026, were $15,300, and for the six months were $31,800.
• Consulting expense to CEO David Tobias was $46,875 per quarter.
• The Company owed David Tobias $775,000 for consulting services and director fees as of June 30, 2026.
• The Company owed the Estate of Brad Herr (prior CFO) $100,000 for consulting and director fees as of June 30, 2026.
• The Company owed COO Mr. Bilton $253,125 for consulting services as of June 30, 2026.
• Cathy Carroll has a consulting agreement for $12,500 quarterly, which increases her note payable.
• The Company had an advance of $75,055 to MJ Harvest, Inc. (a related party) which was allowed for due to uncertainty of repayment after MJ Harvest was delisted.
• An advance of $1,250 was made to a director for consulting services.

Stakeholder Impact

• Shareholders may experience dilution if the company successfully raises capital through equity offerings.
• The going concern status and material weaknesses in internal controls could negatively impact investor confidence.
• Employees may be affected by cost-saving measures, such as decreases in wages and salaries.
• Creditors and suppliers may face increased risk due to the company's weak liquidity position and going concern issues.

Next Steps

• Continue efforts to collect on the $75,055 advance to MJ Harvest.
• Evaluate the acquisition of a cyber liability insurance policy.
• Increase the number of employees to implement adequate segregation of duties within the internal control framework as the Company grows.
• Continue to monitor market developments and evaluate potential impairment or revaluation of digital assets in future periods.

Key Dates

Recommendation

The filing indicates a worsening financial situation with declining revenues, persistent net losses, insufficient liquidity, and a going concern warning. While expense reductions are noted, they do not offset the fundamental challenges. The potential for shareholder dilution from future capital raises further weighs on the outlook, making a sell recommendation appropriate for seasoned investors.

Keywords

telehealth, cannabis, revenue, net loss, operating expenses, going concern, cybersecurity, digital assets